History of radioligand therapy
Readiness assessment framework
UK readiness assessment
Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms
The Health Policy Partnership has published a poster at the 10th European Conference on Rare Diseases & Orphan Products (ECRD).
New poster published at ENETS virtual conference
The Health Policy Partnership presented a poster on radioligand therapy at the European Neuroendocrine Tumor Society (ENETS) conference.
Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan
Recommendations from the radioligand therapy policy report have formed the basis of a submission to Europe’s Beating Cancer Plan, addressing the burden of cancer in the EU.
Policy report on radioligand therapy launched at European Parliament
On 22 January 2020, The Health Policy Partnership and an expert-led steering committee launched a policy report on radioligand therapy at the European Parliament.